Autoimmune and gastrointestinal dysfunctions: Does a subset of children with autism reveal a broader connection?

Department of Complementary & Alternative Medicine, John A Burns School of Medicine, University of Hawaii at Manoa, 651 Ilalo Street, Honolulu, HI 96813, USA.
Expert review of gastroenterology & hepatology (Impact Factor: 2.42). 08/2011; 5(4):465-77. DOI: 10.1586/egh.11.46
Source: PubMed


A large number of autoimmune disorders have a gastrointestinal (GI) dysfunction component that may interplay with genetic, hormonal, environmental and/or stress factors. This narrarive review investigates possible links between autism, immune system abnormalities and GI symptoms in a subgroup of children with autism. A literature search on Medline (1950 to September 2010) was conducted to identify relevant articles by using the keywords 'autism and gastrointestinal' (71 publications) and 'autism and immune' (237 publications), cross-referencing and general searching to evaluate the available literature on the immunological and GI aspects of autism. Sufficient evidence exists to support that a subgroup of children with autism may suffer from concomitant immune-related GI symptoms.

Download full-text


Available from: Amy C. Brown, Jun 17, 2014
  • Source
    • "We can consider some possibilities to explain the higher anti-gliadin antibody levels found in the cohort of children with autism. Previously, associations between autism and increased GI symptoms, as well as impaired intestinal permeability, have been reported [9], [10], [29]. Increased intestinal permeability resulting from damage to the intestinal epithelial barrier in those with autism may be responsible for increased exposure of the immune system to partially digested gluten fragments, resulting in the detected increase in antibody response. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Gastrointestinal symptoms are a common feature in children with autism, drawing attention to a potential association with celiac disease or gluten sensitivity. However, studies to date regarding the immune response to gluten in autism and its association with celiac disease have been inconsistent. The aim of this study was to assess immune reactivity to gluten in pediatric patients diagnosed with autism according to strict criteria and to evaluate the potential link between autism and celiac disease. Study participants included children (with or without gastrointestinal symptoms) diagnosed with autism according to both the Autism Diagnostic Observation Schedule (ADOS) and the Autism Diagnostic Interview, Revised (ADI-R) (n = 37), their unaffected siblings (n = 27), and age-matched healthy controls (n = 76). Serum specimens were tested for antibodies to native gliadin, deamidated gliadin, and transglutaminase 2 (TG2). Affected children were genotyped for celiac disease associated HLA-DQ2 and -DQ8 alleles. Children with autism had significantly higher levels of IgG antibody to gliadin compared with unrelated healthy controls (p<0.01). The IgG levels were also higher compared to the unaffected siblings, but did not reach statistical significance. The IgG anti-gliadin antibody response was significantly greater in the autistic children with gastrointestinal symptoms in comparison to those without them (p<0.01). There was no difference in IgA response to gliadin across groups. The levels of celiac disease-specific serologic markers, i.e., antibodies to deamidated gliadin and TG2, did not differ between patients and controls. An association between increased anti-gliadin antibody and presence of HLA-DQ2 and/or -DQ8 was not observed. A subset of children with autism displays increased immune reactivity to gluten, the mechanism of which appears to be distinct from that in celiac disease. The increased anti-gliadin antibody response and its association with GI symptoms points to a potential mechanism involving immunologic and/or intestinal permeability abnormalities in affected children.
    PLoS ONE 06/2013; 8(6):e66155. DOI:10.1371/journal.pone.0066155 · 3.23 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Secondary to clinical features indicating chronic inflammation and immune dysregulation, the immune system has long been suspected to have a role in autism spectrum disorders (ASD). Studies of postmortem autistic brains indicate the presence of immune mediated chronic inflammation in some but not all autistic brains. However, studies of immune abnormalities in ASD children yielded no conclusive results. Instead, immune abnormalities reported appear to affect almost all aspects of the immune system and are often contradictory. This may be associated with the marked heterogeneity of ASD subjects, since ASD is a behaviorally defined syndrome. In addition, variable co-morbid conditions could affect the immune-parameters, making such analysis very difficult. Alternatively, various immune abnormalities reported may be associated with the fact that ASD is a polygenic condition affected by multiple genetic and environmental factors, resulting in similar behavioral symptoms. At present, it is unknown how the immune system contributes to the onset and progress of ASD. Nevertheless, the results of previous studies indicate the presence of chronic inflammation, in at least a portion of ASD children. This review summarizes previous immunological findings and the problems associated with these studies. The direction that future research needs to take will also be discussed.
    Advances in Neuroimmune Biology 01/2013; 4(3):141-159. DOI:10.3233/NIB-130061
  • [Show abstract] [Hide abstract]
    ABSTRACT: Epidemiological studies have associated infection during pregnancy with increased risk of neurodevelopmental disorders in children, which is modeled in rodents by stimulating the immune system of pregnant dams with microorganisms or their mimics, such as poly(I:C) or LPS. In two prenatal mouse models, we show that in utero exposure of the fetus to cytokines/inflammatory mediators elicited by maternal immune stimulation with poly(I:C) yields offspring that exhibit a proinflammatory phenotype due to alterations in developmental programming of their immune system. Changes in the innate and adaptive immune elements of these pro-inflammatory offspring result in more robust responses following exposure to immune stimuli than those observed in control offspring from PBS-injected pregnant dams. In the first model, offspring from poly(I:C)-injected immunologically naïve dams showed heightened cellular and cytokine responses 4 hrs after injection of zymosan, a TLR2 agonist. In the second model, using dams with immunological memory, poly(I:C) injection during pregnancy produced offspring that showed preferential differentiation toward Th17 cell development, and earlier onset of clinical symptoms of EAE following immunization with MOG35- 55. Such "fetal programming" in offspring from poly(I:C)-injected dams not only persists into neonatal and adult life, but also can have profound consequences on health and disease.
    Brain Behavior and Immunity 05/2013; 33. DOI:10.1016/j.bbi.2013.04.012 · 5.89 Impact Factor
Show more